Clinical Trials Directory

Trials / Completed

CompletedNCT00962962

Exercise Dose-Response Effects in Prediabetes

Exercise Dose-Response Effects in Prediabetes: Responses and Mechanisms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
288 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate the effects of different amounts and intensities of aerobic exercise training programs, with and without weight loss, in people who are at risk for diabetes. An additional purpose of the study is to evaluate the factors in the blood and in exercising muscles that contribute to the improvement in those risk factors. This information will be used to improve exercise training guidelines for improving cardiovascular and metabolic health in people with abnormal fasting glucose, also known as prediabetes.

Detailed description

729 subjects were consented, 288 participants were randomized.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAerobic ExerciseAerobic exercise at 50% peak oxygen use/consumption expending approximately 1,000 calories per week equaling approximately 10 miles per week OR 2.5-3.5 hours per week
BEHAVIORALAerobic ExerciseAerobic exercise at 50% peak oxygen use/consumption expending approximately 1,600 calories per week equaling approximately 16 miles per week OR 4-6 hours per week
BEHAVIORALAerobic ExerciseAerobic exercise at 75% peak oxygen use/consumption expending approximately 1,600 calories per week equaling approximately 16 miles per week OR 2-3 hours per week
BEHAVIORALExercise and Diet* Exercise - 150 minutes per week (30 minutes / 5 days per week) of aerobic exercise at 50% peak oxygen use/consumption equaling approximately 10 miles per week * Diet - The Clinical Lifestyle Intervention sessions will provide training on needed skills (e.g., calorie counting, portion size estimation) as well as motivation and support in a group counseling setting designed to achieve a weight loss goal of 5 to 7% of baseline body weight.

Timeline

Start date
2009-07-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2009-08-20
Last updated
2014-07-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00962962. Inclusion in this directory is not an endorsement.